Over seven million children in the U.S. have been diagnosed with asthma. Many patients only experience mild, intermittent symptoms and can be treated symptomatically with medicines like Abluterol. Most of the remaining patients can achieve good asthma control by using daily medicines to decrease inflammation in the lung.
However, about 10 percent of children with asthma have difficult-to-treat disease. The challenge is identifying new therapies for these patients so they may live free of daily symptoms or the fear of exacerbations.